| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |